Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
11.07
-0.21 (-1.86%)
At close: May 14, 2025, 12:21 PM
-1.86% (1D)
| Bid | 11.01 |
| Market Cap | 160.32M |
| Revenue (ttm) | 200K |
| Net Income (ttm) | 1.69B |
| EPS (ttm) | 112.62 |
| PE Ratio (ttm) | 0.1 |
| Forward PE | -1.54 |
| Analyst | n/a |
| Ask | 11.17 |
| Volume | 14,312 |
| Avg. Volume (20D) | 111,940 |
| Open | 11.14 |
| Previous Close | 11.28 |
| Day's Range | 10.97 - 11.34 |
| 52-Week Range | 10.80 - 18.95 |
| Beta | -0.94 |
About INBX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INBX
Website n/a
6 months ago · seekingalpha.com
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique PlatformINBX's two main pipeline candidates, INBRX-109 and INBRX-106, are entering critical late-stage trials with data readouts expected in mid- to late-2025. INBRX-109 targets DR5 in solid tumors, showing p...